By Anna Ringstrom and Maggie Fick STOCKHOLM/LONDON (Reuters) -Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

The pharmaceutical company will establish a production facility in Odense to accommodate multiple product types within the ...

Danish drugmaker Novo Nordisk will invest 8.5 billion crowns ($1.20 billion) in a new facility in Odense, Denmark, for the ...

New health technology assessment (HTA) statistics produced by Denmark’s Medicine Council (Medicinrådet) for 2024 have ...

Denmark’s biggest pension fund, ATP, is taking a major hit on its 2.3 billion-krone ($324 million) stake in troubled battery ...

The coming year brings both good and bad for homeowners in Denmark. While valuations are now back at peak levels, mortgage ...

Ozempic maker Novo Nordisk A/S is investing 8.5 billion kroner ($1.2 billion) to build a new major factory in Denmark to help ...

Danish healthcare firm Novo Nordisk announced plans on Monday for new investment in a production facility in one of the ...

Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...

Novo Nordisk unveils a $1.2 billion production facility in Denmark and finalizes Catalent acquisition, with financial and ...

Concession payments from offshore wind tenders were supposed to part-finance transmission link from planned Bornholm energy ...